PMID: 9188022Apr 1, 1997Paper

Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: a retrospective analysis

Journal of Geriatric Psychiatry and Neurology
J R SwartzD F Benson

Abstract

Often patients in the early stages of Alzheimer's disease (AD), frontotemporal dementia (FTD), and late-life depression can be difficult to differentiate clinically. Although subtle cognitive distinctions exist between these disorders, noncognitive behavioral phenomenology may provide additional discriminating power. In 19 subjects with AD, 19 with FTD, 16 with late-life psychotic depression (LLPD), and 19 with late-life nonpsychotic depression (LLNPD), noncognitive behavioral symptoms were quantified retrospectively using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) and compared using both a one-way ANOVA and a multivariate stepwise discriminant analysis, which utilized a jackknife procedure. The FTD group showed the highest mean total SCAN score, while the AD group showed the lowest. ANOVA showed significant differences in the mean total SCAN scores between the four diagnostic groups (P < .0001). With the discriminant analysis, the four disorders demonstrated different clusters of behavioral abnormalities and were differentiated by these symptoms (P < .0001). A subset of 14 SCAN item group symptoms was identified that collectively classified the following percentages of subjects in each diagnostic category:...Continue Reading

References

Oct 1, 1976·Archives of General Psychiatry·M AsbergP Thorén
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Aug 1, 1991·Archives of Neurology·D L Sparks, W R Markesbery
May 1, 1991·The American Journal of Psychiatry·P V RabinsK Dowell
Jun 1, 1990·Archives of General Psychiatry·J K WingN Sartorius
Jan 1, 1990·Journal of Psychiatric Research·A KumarR P Friedland
Oct 1, 1990·Archives of Neurology·G S ZubenkoG L Wolf
Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·D DewarJ McCulloch
Jul 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A BurnsR Levy
Oct 1, 1990·The American Journal of Psychiatry·J L MartinotA Syrota
May 1, 1989·The American Journal of Psychiatry·R E Wragg, D V Jeste
Mar 1, 1989·Archives of General Psychiatry·L R BaxterR M Sumida
Nov 1, 1989·The American Journal of Psychiatry·B S GreenwaldK L Davis
Mar 1, 1989·The American Journal of Psychiatry·B W RovnerM F Folstein
Sep 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·D NearyH J Testa
May 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·N L Holden
Apr 1, 1987·Archives of Neurology·J L CummingsR Neshkes
Mar 1, 1985·Neurology·J L CummingsS Read
Jan 1, 1974·European Neurology·J ConstantinidisR Tissot
Aug 7, 1969·The New England Journal of Medicine·J J Schildkraut
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jun 1, 1982·The American Journal of Psychiatry·G L BrownF K Goodwin
May 1, 1981·Annals of Neurology·R G Robinson, B Szetela
Nov 1, 1980·The American Journal of Psychiatry·R J MathewJ L Claghorn
Jan 1, 1991·The Journal of Neuropsychiatry and Clinical Neurosciences·I M LesserI Mena
Apr 1, 1995·The American Journal of Psychiatry·I M AndersonG Harborne
Oct 1, 1994·Journal of Geriatric Psychiatry and Neurology·K V WildB S Oken
Aug 1, 1994·Acta Psychiatrica Scandinavica·A JancaN Sartorius
Mar 1, 1994·International Clinical Psychopharmacology·B E Leonard
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·J M TonkonogyP J Barreira
Sep 1, 1994·Archives of General Psychiatry·I M LesserM Wohl
Jul 1, 1993·Acta Neurologica Scandinavica·G BinettiM Trabucchi
Jan 1, 1993·Archives of General Psychiatry·C E CoffeyC E Spritzer

❮ Previous
Next ❯

Citations

Dec 21, 2000·Current Psychiatry Reports·J S Snowden, D Neary
Dec 21, 2000·Current Psychiatry Reports·T W Chow
Oct 19, 2001·International Journal of Geriatric Psychiatry·N PurandareK Scott
Oct 24, 2002·American Journal of Alzheimer's Disease and Other Dementias·Tiffany W Chow, Mario F Mendez
Apr 15, 2009·Journal of Neurology·Rohani OmarJason D Warren
Jan 12, 2010·Journal of Clinical and Experimental Neuropsychology·Jane L Mathias, Kylie Morphett
May 20, 2014·American Journal of Alzheimer's Disease and Other Dementias·Adolfo Jiménez-HueteOriol Franch
Aug 10, 2016·Journal of Geriatric Psychiatry and Neurology·Tor Atle RosnessZeina Chemali
Dec 16, 1998·Current Opinion in Neurology·F Pasquier, A Delacourte
Nov 24, 2004·American Journal of Alzheimer's Disease and Other Dementias·Erin L Cidboy
May 4, 2004·CNS Spectrums·Thomas Benke, Elfriede Karner
Jul 2, 2003·International Journal of Geriatric Psychiatry·A GräsbeckL Gustafson
Dec 1, 2005·Alzheimer Disease and Associated Disorders·Adam L Boxer, Bruce L Miller
Oct 12, 2005·Current Psychiatry Reports·Tiffany W Chow
Nov 16, 2007·Journal of Geriatric Psychiatry and Neurology·James A Levy, Gordon J Chelune
Nov 8, 2008·Current Opinion in Neurology·Keith A Vossel, Bruce L Miller
Jul 3, 2013·American Journal of Alzheimer's Disease and Other Dementias·Sayantani Ghosh, Carol F Lippa
Nov 3, 2020·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Mandy VisserFiona Kumfor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.